同步放化疗的食管癌患者的饮食护理(1)
[摘要] 目的 探究在食管癌患者同步放化疗期间饮食护理干预临床影响。方法 方便选取2018年1月—2020年1月期间46例食管癌同步放化疗患者为研究对象，随机分为常规组(23例，实施静脉或胃肠道营养支持)、饮食组(23例，实施常规组营养支持方式+饮食护理)，比较两组患者干预前后营养水平(白蛋白、血红蛋白)、生命质量及不良发应情况。结果 饮食组患者生活质量中各项评分比常规组高，差异有统计学意义(P<0.05)，干预后饮食组患者白蛋白(38.67±3.52)g/L、血红蛋白(122.36±14.03)g/L均较常规组(33.12±3.45)g/L、(105.67±10.39)g/L高，差异有统计学意义(t=5.400、4.585，P<0.05);饮食组同步放化疗期间不良反应发生率8.70%较常规组34.78%低，差异有统计学意义(χ2=4.600，P<0.05)。 结论 对同步放化疗治疗的食管癌患者实施饮食护理干预，取得成效确切。
[关键词] 食管癌;同步放化疗;营养水平
[中图分类号] R47 [文献标识码] A [文章编号] 1674-0742(2020)10(a)-0131-03
Diet Nursing of Patients with Esophageal Cancer Undergoing Concurrent Radiotherapy and Chemotherapy
LIU Hui
Department of Radiation Oncology， Xinyi People's Hospital， Xinyi， Jiangsu Province， 221400 China
[Abstract] Objective To explore the clinical impact of diet nursing intervention in patients with esophageal cancer during concurrent radiotherapy and chemotherapy. Methods From January 2018 to January 2020， 46 patients with concurrent radiotherapy and chemotherapy for esophageal cancer were convenient selected as the research objects， and they were randomly divided into the conventional group (23 cases， with intravenous or gastrointestinal nutritional support) and the diet group (23 cases， with the implementation of routine group nutritional support method + diet nursing)， compare the nutritional level (albumin， hemoglobin)， quality of life and adverse reactions of the two groups before and after intervention. Results The scores of the quality of life of the diet group were higher than those of the routine group，and the difference was statistically significant(P<0.05). After the intervention， the diet group patients' albumin (38.67±3.52)g/L and hemoglobin (122.36±14.03) g/L were higher than those of the routine group (33.12±3.45)g/L， (105.67±10.39)g/L，and the difference was statistically significant(t=5.400， 4.585， P<0.05); the incidence of adverse reactions during concurrent radiotherapy and chemotherapy in the diet group was 8.70% lower than that of the routine group 34.78%，and the difference was statistically significant(χ2=4.600， P<0.05). Conclusion The implementation of diet nursing intervention for patients with esophageal cancer treated with concurrent radiotherapy and chemotherapy has achieved definite results.
[Key words] Esophageal cancer; Concurrent radiotherapy and chemotherapy; Nutritional level
食管癌為临床常见恶性肿瘤，发病率、病死率较高[1]。近年来随生活方式、饮食结构的改变，其发生率呈现逐年升高趋势，严重威胁患者生命安全[2]。同步放化疗为在缩小肿瘤体积基础上清除全身转移肿瘤细胞治疗方式，但在治疗期间极易出现多种不良反应，严重影响患者治疗依从性[3]。相关研究[4]表示，在对食管癌患者同步放化疗期间，加强其营养干预可提升患者治疗耐受能力，进而达到提升机体功能、降低不良反应发生率、改善生活质量的效果。食管癌患者一般存在吞咽功能障碍，因此临床对其营养支持以全静脉营养为主，但在临床研究中发现，对仍具有吞咽功能患者实施饮食护理进一步提升其营养水平、提升同步放化疗耐受能力。为此，该次方便选取2018年1月—2020年1月期间46例食管癌同步放化疗患者为研究对象，探究饮食护理干预对其影响。现报道如下。, 百拇医药(刘慧)
[关键词] 食管癌;同步放化疗;营养水平
[中图分类号] R47 [文献标识码] A [文章编号] 1674-0742(2020)10(a)-0131-03
Diet Nursing of Patients with Esophageal Cancer Undergoing Concurrent Radiotherapy and Chemotherapy
LIU Hui
Department of Radiation Oncology， Xinyi People's Hospital， Xinyi， Jiangsu Province， 221400 China
[Abstract] Objective To explore the clinical impact of diet nursing intervention in patients with esophageal cancer during concurrent radiotherapy and chemotherapy. Methods From January 2018 to January 2020， 46 patients with concurrent radiotherapy and chemotherapy for esophageal cancer were convenient selected as the research objects， and they were randomly divided into the conventional group (23 cases， with intravenous or gastrointestinal nutritional support) and the diet group (23 cases， with the implementation of routine group nutritional support method + diet nursing)， compare the nutritional level (albumin， hemoglobin)， quality of life and adverse reactions of the two groups before and after intervention. Results The scores of the quality of life of the diet group were higher than those of the routine group，and the difference was statistically significant(P<0.05). After the intervention， the diet group patients' albumin (38.67±3.52)g/L and hemoglobin (122.36±14.03) g/L were higher than those of the routine group (33.12±3.45)g/L， (105.67±10.39)g/L，and the difference was statistically significant(t=5.400， 4.585， P<0.05); the incidence of adverse reactions during concurrent radiotherapy and chemotherapy in the diet group was 8.70% lower than that of the routine group 34.78%，and the difference was statistically significant(χ2=4.600， P<0.05). Conclusion The implementation of diet nursing intervention for patients with esophageal cancer treated with concurrent radiotherapy and chemotherapy has achieved definite results.
[Key words] Esophageal cancer; Concurrent radiotherapy and chemotherapy; Nutritional level
食管癌為临床常见恶性肿瘤，发病率、病死率较高[1]。近年来随生活方式、饮食结构的改变，其发生率呈现逐年升高趋势，严重威胁患者生命安全[2]。同步放化疗为在缩小肿瘤体积基础上清除全身转移肿瘤细胞治疗方式，但在治疗期间极易出现多种不良反应，严重影响患者治疗依从性[3]。相关研究[4]表示，在对食管癌患者同步放化疗期间，加强其营养干预可提升患者治疗耐受能力，进而达到提升机体功能、降低不良反应发生率、改善生活质量的效果。食管癌患者一般存在吞咽功能障碍，因此临床对其营养支持以全静脉营养为主，但在临床研究中发现，对仍具有吞咽功能患者实施饮食护理进一步提升其营养水平、提升同步放化疗耐受能力。为此，该次方便选取2018年1月—2020年1月期间46例食管癌同步放化疗患者为研究对象，探究饮食护理干预对其影响。现报道如下。, 百拇医药(刘慧)